measl
viru
pleomorph
envelop
negativesens
singlestrand
rna
viru
famili
paramyxovirida
approxim
nm
nm
diamet
measl
viru
caus
mild
sever
ill
season
outbreak
endem
area
intermitt
outbreak
nonendem
area
measl
viru
code
six
structur
two
nonstructur
protein
fig
hemagglutinin
h
fusion
f
glycoprotein
project
viral
surfac
facilit
viral
bind
cellular
receptor
fusion
host
cell
membran
respect
matrix
protein
underli
envelop
provid
structur
inner
nucleocapsid
compos
rna
coat
nucleoprotein
n
bound
polymeras
complex
includ
larg
l
polymeras
protein
phosphoprotein
p
polymeras
cofactor
remain
nonstructur
protein
includ
c
v
coronavirus
spheric
envelop
positivesens
singlestrand
rna
virus
famili
coronavirida
approxim
nm
diamet
coronavirus
caus
agent
estim
upper
lower
respiratori
tract
infect
human
result
rhiniti
pharyng
sinus
bronchiol
pneumonia
coronavirus
often
associ
mild
diseas
eg
sever
acut
respiratori
syndrom
coronaviru
sarscov
lineag
b
betacoronaviru
middl
east
respiratori
syndrom
coronaviru
merscov
lineag
c
betacoronaviru
associ
sever
potenti
fatal
respiratori
infect
sarsand
merscov
transcrib
subgenom
rna
respect
encod
spike
envelop
e
membran
nucleocapsid
n
structur
protein
fig
e
integr
hostderiv
lipid
envelop
facilit
host
cell
attach
angiotensinconvert
enzym
ace
receptor
sarscov
dipeptidyl
peptidas
dpp
receptor
merscov
n
protein
encapsid
viral
genom
form
helic
nucleocapsid
viral
replicasetranscriptas
complex
made
nonstructur
protein
includ
uniqu
proofread
exoribonucleas
reduc
accumul
genom
mutat
poxvirus
ovaltobrickshap
doublestrand
dna
virus
famili
poxvirida
rang
size
nm
virus
within
genu
orthopoxviru
caus
human
diseas
includ
cowpox
viru
cpxv
monkeypox
viru
mpxv
vaccinia
viru
vacv
variola
viru
varv
etiolog
agent
smallpox
poxvirus
contain
biconcav
viral
core
dna
genom
dnadepend
rna
polymeras
enzym
necessari
particl
uncoat
resid
fig
nucleosom
surround
core
membran
flank
two
proteinac
later
bodi
singl
lipid
membran
surround
cellassoci
form
matur
virion
mv
second
hostderiv
lipid
envelop
cover
extracellular
virion
ev
poxviru
genom
compris
larg
linear
doublestrand
viral
dna
genom
encod
gene
highli
conserv
structur
gene
predominantli
found
middl
genom
wherea
variabl
virul
factor
gene
function
immun
evas
virul
viral
pathogenesi
found
termini
genom
wild
aquat
bird
natur
reservoir
nearli
influenza
viru
subtyp
spread
domest
avian
speci
mammal
includ
human
subtyp
except
isol
bat
certain
subtyp
highli
pathogen
domest
poultri
transmit
wild
bird
known
highli
pathogen
avian
influenza
hpai
virus
hpai
virus
caus
spillov
infect
human
may
sever
fatal
exampl
includ
outbreak
hpai
virus
asia
high
case
fatal
among
human
although
limit
humantohuman
transmiss
report
hpai
viru
adapt
might
lead
sustain
humantohuman
transmiss
poultri
outbreak
manag
flock
depopul
influenza
subtyp
isol
swine
includ
subtyp
spillov
human
caus
mild
sever
ill
known
swine
variant
virus
current
circul
season
influenza
subtyp
influenza
b
virus
yamagata
victoria
lineag
caus
annual
epidem
fall
spring
temper
region
infect
throughout
year
tropic
antigen
drift
h
n
surfac
glycoprotein
drive
annual
epidem
season
influenza
caus
approxim
million
ill
million
hospit
death
unit
state
alon
two
influenza
virus
infect
common
host
bird
pig
individu
gene
segment
may
recombin
form
novel
viru
known
antigen
shift
influenza
pandem
occur
novel
virus
emerg
immunolog
popul
becom
adapt
sustain
humantohuman
spread
spanish
influenza
pandem
sever
record
result
estim
million
death
less
sever
pandem
occur
effort
improv
prepared
respons
season
pandem
zoonot
influenza
world
health
organ
conduct
global
surveil
influenza
b
isol
fig
measl
pathogen
human
nonhuman
primat
although
sustain
transmiss
occur
among
human
rais
potenti
global
elimin
histor
measl
infect
estim
children
age
year
result
approxim
million
global
death
year
introduct
measl
vaccin
advanc
global
vaccin
program
measl
case
mortal
drastic
declin
fig
children
worldwid
receiv
least
one
dose
measl
vaccin
age
year
global
measl
mortal
decreas
prevent
estim
million
death
known
measl
genotyp
five
detect
circul
despit
gain
measl
remain
endem
mani
region
world
includ
africa
western
pacif
south
east
asia
europ
measl
resurg
previous
lowincid
area
eg
region
within
europ
america
epidem
attribut
import
case
suboptim
immun
coverag
estim
popul
immun
requir
prevent
measl
transmiss
within
commun
prerequisit
global
elimin
chines
horsesho
bat
put
reservoir
sarscov
dromedari
camel
thought
reservoir
merscov
animaltohuman
transmiss
like
occur
follow
direct
contact
intermedi
host
sar
epidem
case
death
report
countri
case
report
sinc
fig
humantohuman
transmiss
sarscov
occur
primarili
healthcar
set
healthcar
worker
compris
report
case
china
canada
respect
mer
first
report
saudi
arabia
case
death
report
countri
case
report
arabian
peninsula
import
case
south
korea
result
larg
outbreak
multipl
healthcar
facil
mer
transmiss
occur
primarili
healthcar
facil
lesser
degre
within
household
known
reservoir
varv
human
postul
viru
emerg
ancestr
rodentborn
poxviru
year
ago
numer
smallpox
epidem
occur
throughout
record
histori
includ
million
fatal
twentieth
centuri
alon
smallpox
eventu
erad
follow
implement
smallpox
erad
program
fig
facilit
absenc
zoonot
reservoir
varv
influenza
virus
transmit
larg
respiratori
droplet
cough
sneez
talk
contact
infect
surfac
influenza
virus
bind
sugar
moieti
surfac
airway
epitheli
cell
earli
viral
replic
propag
shed
occur
averag
day
incub
period
peak
viral
replic
typic
occur
within
day
symptom
onset
resolv
within
day
last
longer
children
immunocompromis
host
averag
one
person
infect
one
two
addit
peopl
howev
reproduct
number
r
vari
viral
strain
social
environment
factor
viral
infect
impair
airway
mucos
barrier
disrupt
alveolarcapillari
membran
contribut
leakag
fluid
inflammatori
cell
alveolar
space
impair
ga
exchang
result
hypoxemia
bacteri
coinfect
often
complic
sever
case
contribut
respiratori
failur
death
staphylococcu
aureu
streptococcu
speci
predomin
copathogen
season
influenza
viru
infect
larg
limit
respiratori
tract
howev
hpai
virus
polybas
cleav
site
within
hemagglutinin
allow
replic
outsid
respiratori
tract
infect
one
strain
influenza
confer
complet
immun
strain
subtyp
measl
among
highli
contagi
respiratori
infect
spread
exposur
larg
respiratori
droplet
cough
sneez
talk
indirect
contact
infect
surfac
small
infecti
droplet
remain
suspend
air
hour
respiratori
tract
dendrit
cell
lymphocyt
alveolar
macrophag
earli
target
infect
averag
incub
period
measl
replic
spread
local
lymphat
respiratori
epithelium
dissemin
blood
via
infect
lymphocyt
epitheli
endotheli
cell
organ
infecti
period
begin
fever
onset
extend
sever
day
rash
appear
estim
r
measl
depend
upon
host
suscept
social
environment
factor
measl
infect
disrupt
tissu
throughout
bodi
howev
sever
diseas
primarili
due
lower
respiratori
tract
neurolog
complic
natur
measl
infect
confer
lifelong
immun
passiv
transfer
matern
antibodi
protect
newborn
earli
postnat
period
individu
recov
measl
infect
increas
risk
secondari
infect
sarscov
transmit
larg
respiratori
droplet
contact
infect
surfac
epidemiolog
data
also
support
small
droplet
airborn
transmiss
sarscov
although
estim
r
argu
predomin
rout
spread
sarscov
bind
angiotensinconvert
enzym
ace
receptor
respiratori
epitheli
cell
pneumocyt
alveolar
macrophag
result
diffus
alveolar
damag
respiratori
failur
sar
system
infect
viremia
detect
case
affect
multipl
cell
type
organ
acut
kidney
injuri
multifactori
evid
acut
tubul
necrosi
vascul
glomerular
fibrosi
central
nervou
system
manifest
least
part
attribut
direct
infect
neuron
result
edema
degener
merscov
transmit
larg
respiratori
droplet
contact
infect
surfac
estim
outsid
versu
within
healthcar
set
respect
merscov
bind
dipeptidyl
peptidas
respiratori
epitheli
cell
pneumocyt
undergo
product
replic
day
incub
period
viral
shed
lower
respiratori
tract
may
persist
week
viremia
document
case
associ
sever
diseas
product
infect
dc
macrophag
thought
facilit
immun
dysregul
broadli
express
cell
outsid
lung
howev
autopsi
data
avail
defin
viral
distribut
varv
transmit
primarili
larg
respiratori
droplet
lesser
degre
contact
contamin
object
scab
bed
cloth
airborn
small
respiratori
droplet
varv
thought
replic
airway
epithelium
spread
region
lymph
node
varv
replic
within
lymph
node
dissemin
via
bloodstream
seed
distant
sight
includ
skin
spleen
bone
marrow
liver
kidney
organ
fever
manifest
follow
averag
day
incub
rash
follow
fever
day
concurr
highlevel
viral
shed
oropharyng
secret
estim
r
smallpox
highlevel
viremia
detect
often
hemorrhag
compar
ordinari
type
smallpox
although
exact
mechan
organ
failur
observ
fatal
case
well
defin
influenza
infect
manifest
acut
onset
fever
chill
malais
headach
myalgia
follow
averag
day
asymptomat
incub
period
infect
selflimit
resolv
within
week
upper
lower
airway
complic
includ
otiti
media
sinus
bronchiti
pneumonia
without
bacteri
coinfect
risk
factor
sever
infect
includ
age
year
year
pregnanc
preexist
respiratori
cardiac
neurolog
metabol
condit
immunosuppress
obes
progress
lethargi
short
breath
typic
within
day
symptom
onset
suggest
develop
lower
respiratori
tract
complic
may
rapidli
progress
respiratori
failur
death
sever
case
pneumonia
due
influenza
infect
alon
versu
influenza
bacteri
coinfect
reliabl
distinguish
clinic
radiolog
ground
high
index
suspicion
need
influenza
complic
outsid
respiratori
tract
includ
exacerb
underli
heart
diseas
includ
ischem
heart
diseas
heart
failur
myocard
encephalopathi
enceph
measl
infect
manifest
acut
onset
fever
coryza
conjunct
cough
small
white
papul
koplik
spot
appear
buccal
mucosa
within
day
fever
onset
follow
develop
diffus
maculopapular
rash
day
later
diarrhea
commonli
begin
shortli
follow
rash
onset
may
result
dehydr
symptom
typic
resolv
within
day
fever
onset
selflimit
ill
group
increas
risk
measl
complic
includ
malnourish
infant
vitamin
defici
adult
year
old
immunocompromis
individu
respiratori
complic
includ
otiti
media
laryngotracheobronch
croup
pneumonia
pneumonia
often
complic
bacteri
coinfect
common
sever
complic
measl
contribut
respiratori
failur
death
predomin
bacteri
copathogen
includ
streptococcu
pneumonia
staphylococcu
aureu
haemophilu
influenza
three
rare
sever
neurolog
complic
occur
acut
dissemin
encephalomyel
adem
demyelin
autoimmun
process
occur
within
week
acut
ill
approxim
case
adem
character
fever
seizur
neurolog
deficit
measl
inclus
bodi
enceph
progress
lethal
brain
infect
occur
within
month
acut
ill
primarili
among
individu
impair
cellular
immun
subacut
scleros
panenceph
sspe
occur
year
follow
initi
infect
result
seizur
cognit
motor
declin
result
death
sspe
affect
estim
infant
year
age
attribut
host
respons
defect
viral
particl
product
brain
follow
averag
incub
period
sarscov
infect
present
fever
chill
dri
cough
headach
malais
dyspnea
commonli
follow
wateri
diarrhea
age
year
pregnanc
associ
sever
diseas
manifest
progress
respiratori
failur
within
week
ill
onset
common
laboratori
featur
sar
includ
lymphopenia
thrombocytopenia
abnorm
coagul
paramet
elev
lactat
dehydrogenas
alanin
aminotransferas
creatin
kinas
level
acut
kidney
injuri
proteinuria
observ
patient
respect
initi
symptom
merscov
infect
includ
fever
chill
cough
short
breath
myalgia
malais
follow
mean
incub
period
day
gastrointestin
symptom
includ
vomit
diarrhea
occur
onethird
patient
median
time
symptom
onset
hospit
icu
admiss
death
day
respect
mer
patient
present
rapidli
progress
pneumonia
requir
mechan
ventil
addit
organ
support
first
week
ill
sever
diseas
link
comorbid
includ
diabet
mellitu
chronic
renal
diseas
hypertens
chronic
cardiac
diseas
chronic
pulmonari
diseas
obes
median
age
confirm
mer
year
maletofemal
ratio
laboratori
abnorm
includ
lymphopenia
leukopenia
thrombocytopenia
elev
serum
creatinin
level
consist
acut
kidney
injuri
elev
liver
enzym
high
lactat
level
consumpt
coagulopathi
also
report
chest
radiograph
abnorm
due
viral
pneumon
without
secondari
bacteri
pneumonia
acut
kidney
injuri
occur
patient
smallpox
diseas
cours
relat
clinic
present
diseas
rao
propos
clinic
classif
system
later
adopt
ordinari
type
smallpox
common
clinic
type
smallpox
incub
period
day
follow
fever
onset
headach
backach
vomit
diarrhea
lesion
first
appear
mucou
membran
includ
tongu
palat
pharynx
day
prior
macular
rash
develop
lesion
began
face
follow
proxim
region
extrem
trunk
distal
extrem
lesion
develop
follow
centrifug
dispers
pattern
typic
dens
face
papul
appear
within
day
macular
rash
develop
papul
becam
vesicular
day
later
follow
pustular
stage
day
postrash
peak
day
postrash
pustul
resolut
quickli
follow
accompani
lesion
flatten
fluid
reabsorpt
harden
scab
format
day
postrash
rao
propos
ordinari
type
smallpox
subdivid
base
macular
rash
pattern
includ
discret
ordinarytyp
smallpox
character
discret
skin
lesion
confluent
ordinarytyp
smallpox
pustular
skin
lesion
confluent
face
extrem
semiconflu
ordinarytyp
smallpox
skin
lesion
confluent
face
dispar
rest
bodi
modifiedtyp
smallpox
lesion
less
numer
ordinarytyp
smallpox
primarili
associ
vaccin
individu
acceler
nonfat
diseas
cours
flattyp
hemorrhagictyp
smallpox
lethal
form
diseas
also
rare
patient
respect
flattyp
smallpox
high
cfr
unvaccin
vaccin
patient
respect
hemorrhagictyp
smallpox
nearli
fatal
vaccin
unvaccin
individu
death
normal
came
prior
macular
rash
develop
clinic
symptom
flattyp
smallpox
sever
prodrom
period
subsid
skin
lesion
flat
often
black
dark
purpl
respiratori
complic
common
patient
febril
throughout
diseas
death
typic
occur
day
postfev
onset
hemorrhagictyp
smallpox
could
divid
earli
late
hemorrhagictyp
smallpox
earli
form
character
hemorrhag
primarili
subconjunctiv
earli
diseas
cours
gener
erythema
petechia
ecchymosi
within
day
fever
flat
matter
lesion
form
across
entir
bodi
surfac
lesion
turn
purpl
day
death
day
result
cardiac
pulmonari
complic
late
form
hemorrhag
occur
follow
rash
develop
death
follow
day
postfev
onset
healthcar
set
patient
evalu
influenza
isol
standard
droplet
contact
precaut
implement
tradit
antigenbas
rapid
diagnost
assay
rda
influenza
lack
sensit
reli
upon
rule
infect
newer
antigenbas
rda
employ
digit
scan
test
strip
molecular
assay
employ
isotherm
amplif
technolog
improv
sensit
specif
close
approxim
highli
sensit
specif
revers
transcriptas
polymeras
chain
reaction
rtpcr
base
assay
accept
sampl
type
influenza
test
includ
nasopharyng
swab
wash
bronchoalveolar
lavag
specimen
individu
suspect
zoonot
influenza
infect
case
evalu
specimen
test
coordin
local
state
public
health
author
measl
consid
patient
without
preexist
immun
compat
febril
rash
ill
travel
region
ongo
measl
transmiss
exposur
individu
febril
rash
ill
rais
suspicion
patient
evalu
measl
requir
isol
implement
standard
airborn
contact
precaut
local
state
health
author
contact
within
hour
assist
confirmatori
test
case
find
infect
control
measl
typic
confirm
measlesspecif
igm
serolog
detect
measl
rna
nasopharyng
throat
urin
specimen
rtpcr
fourfold
greater
rise
measl
igg
titer
acut
convalesc
sampl
test
week
apart
assist
diagnost
uncertainti
viru
also
cultur
respiratori
blood
urin
specimen
appropri
public
health
laboratori
sar
longer
circul
mer
suspect
individu
compat
febril
ill
epidemiolog
risk
factor
risk
factor
includ
travel
arabian
peninsula
contact
confirm
suspect
case
within
day
symptom
onset
patient
evalu
mer
requir
isol
implement
standard
airborn
contact
precaut
confirmatori
test
infect
control
coordin
local
state
health
author
mer
may
confirm
design
public
health
laboratori
rtpcr
test
lower
respiratori
tract
specimen
multipl
specimen
type
includ
upper
respiratori
tract
sampl
serum
stool
also
collect
test
serolog
test
use
evalu
suspect
infect
among
individu
longer
shed
viru
smallpox
observ
year
howev
concern
remain
use
bioweapon
major
minor
criteria
establish
assist
clinician
recognit
smallpox
individu
evalu
isol
standard
airborn
contact
precaut
implement
local
state
health
author
contact
assist
confirmatori
test
public
health
intervent
pcr
identif
variola
dna
isol
viru
clinic
specimen
requir
confirm
diagnosi
special
highcontain
laboratori
annual
season
influenza
vaccin
recommend
unit
state
individu
age
month
older
associ
decreas
risk
pneumonia
death
particularli
among
highrisk
group
season
influenza
vaccin
provid
protect
novel
strain
consequ
effort
underway
develop
vaccin
would
protect
influenza
strain
three
class
drug
licens
treatment
influenza
unit
state
adamantan
includ
amantadin
rimantadin
current
recommend
given
resist
circul
season
strain
baloxavir
morboxil
capdepend
endonucleas
inhibitor
recent
approv
treatment
uncompl
influenza
neuraminidas
inhibitor
nai
includ
oral
oseltamivir
inhal
zanamivir
intraven
peramivir
prophylact
use
nai
recommend
unvaccin
individu
risk
factor
sever
diseas
institut
outbreak
limit
spread
therapeut
use
recommend
individu
suspect
confirm
influenza
develop
high
risk
influenza
complic
influenza
complic
includ
respiratori
multiorgan
failur
manag
support
care
bacteri
coinfect
consid
empir
treat
earli
pend
result
microbiolog
test
among
sever
case
measl
effect
prevent
vaccin
typic
given
combin
vaccin
rubella
mr
mump
mmr
varicella
mmrv
recommend
first
dose
measl
vaccin
administ
month
age
high
low
preval
set
respect
second
dose
administ
minimum
interv
nonimmun
individu
expos
measl
receiv
postexposur
prophylaxi
mmr
immunoglobulin
within
hour
day
respect
although
concurr
clinic
manag
patient
measl
consist
fluid
electrolyt
nutrit
support
earli
recognit
treatment
bacteri
coinfect
two
dose
vitamin
children
year
associ
reduc
risk
pneumonia
death
recommend
administ
iu
vitamin
daili
day
children
age
year
older
reduc
dose
younger
infant
current
licens
therapeut
vaccin
sar
mer
consequ
support
care
mainstay
treatment
renal
replac
therapi
frequent
requir
sever
ill
empir
antibiot
often
administ
given
potenti
secondari
bacteri
infect
ribavirin
pegyl
interferon
alpha
administ
mer
patient
although
effect
data
lack
aerosolgener
procedur
includ
endotrach
intub
associ
increas
risk
healthcar
worker
infect
necessit
strict
adher
infect
control
measur
includ
use
eye
protect
addit
standard
airborn
contact
precaut
routin
smallpox
vaccin
ceas
end
smallpox
erad
program
still
employ
increas
risk
exposur
firstgener
vaccin
compris
signific
proport
us
nation
global
vaccin
stockpil
howev
firstgener
vaccin
carri
high
risk
advers
event
due
use
replicationcompet
vacv
potenti
manufactur
contamin
secondgener
smallpox
vaccin
reduc
concern
contamin
expect
similar
protect
efficaci
firstgener
vaccin
garner
us
food
drug
administr
licensur
vaccin
high
risk
orthopoxviru
exposur
part
us
strateg
nation
stockpil
listerderiv
vaccin
rivm
elstreebn
also
contribut
global
stockpil
imvamun
mva
thirdgener
vaccin
licens
europ
canada
part
us
nation
stockpil
passiv
immun
vig
employ
treat
complic
vaccin
also
increas
interest
develop
licensur
small
molecul
antivir
treatment
orthopoxviru
infect
brincidofovir
dna
synthesi
inhibitor
demonstr
protect
lethal
varv
nonhuman
primat
grant
ophan
drug
design
also
includ
us
strateg
nation
stockpil
tecovirimat
inhibit
viral
egress
potent
select
mm
inhibitori
activ
multipl
orthopoxviru
antipoxviru
therapeut
grant
approv
us
ad
strateg
nation
stockpil
